Personalized Medicine To Be HHS Focus In Administration’s Final Thousand Days, Leavitt Says
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS Secretary says “reinventing” FDA’s regulatory process and providing new financing mechanisms will be essential to bring about personalized therapies.